RxSight, Inc. to Present at the Bank of America Healthcare Conference

Rhea-AI Summary

RxSight (NASDAQ:RXST) will present at the Bank of America Healthcare Conference on Wednesday, May 13, 2026 at 3:00 p.m. PT. Management will take part in a fireside chat. A live and archived webcast will be available on the company’s investor relations website.

News Market Reaction – RXST

+3.82%

2 alerts

+3.82% Session close to close

$279.37M Market Cap

0.1x Rel. Volume

In the Apr 30 session, RXST gained 3.82%, reflecting a moderate positive market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights RxSight’s continued presence at major healthcare investor conferences, ...

Analysis

This announcement highlights RxSight’s continued presence at major healthcare investor conferences, adding to earlier participation at the Needham Virtual Healthcare Conference on Apr 16, 2026. In recent months, the company also reported 2025 results with revenue of $134.5M and a net loss of $38.9M, alongside 2026 guidance. Investors tracking the story may focus on upcoming earnings on May 6, 2026 and how management commentary at conferences aligns with that guidance and recent operating trends.

Key Figures

Conference fireside chat time: 3:00 p.m. Pacific Time

1 metrics

Conference fireside chat time 3:00 p.m. Pacific Time Bank of America Healthcare Conference on May 13, 2026

Historical Context

5 past events · Latest: Apr 22 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 22	Earnings date notice	Neutral	-2.7%	Set timing for Q1 2026 results and conference call logistics.
Apr 08	Product milestone update	Positive	-7.0%	Surpassed 300,000 LAL implants and highlighted ASCRS 2026 presence.
Apr 02	Conference participation	Neutral	+5.7%	Announced fireside chat at Needham Virtual Healthcare Conference.
Feb 25	Earnings and guidance	Negative	-10.1%	Reported 2025 results and 2026 guidance with net loss and revenue drop.
Feb 11	Earnings date notice	Neutral	-2.9%	Announced date and time for Q4 and full-year 2025 results call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Positive and operational updates have sometimes seen negative reactions, while major earnings results drew a notably larger selloff.

Recent Company History

This announcement adds to a series of visibility and fundamental updates for RxSight. On Feb 25, 2026, the company reported 2025 results with $134.5M revenue, $103.0M gross profit and a net loss of $38.9M, which coincided with a -10.1% move. Since then, RxSight has issued two earnings-date notices that preceded modest declines of -2.86% and -2.7%. A Needham conference participation on Apr 2, 2026 saw a +5.72% reaction, while an ASCRS milestone update on Apr 8 drew a -7.01% move despite positive operating metrics.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ALISO VIEJO, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., today announced plans to participate in the upcoming Bank of America Healthcare Conference. Management is scheduled to participate in a fireside chat on Wednesday, May 13, 2026, at 3:00 p.m. Pacific Time. A live and archived webcast of the presentation will be available on the company’s investor relations website at https://investors.rxsight.com/.

About RxSight, Inc.

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight^® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens^® (LAL^®/LAL+^®, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.

Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com

FAQ

When will RxSight (RXST) present at the Bank of America Healthcare Conference?

RxSight will present on Wednesday, May 13, 2026 at 3:00 p.m. Pacific Time. According to RxSight, management is scheduled for a fireside chat during that session and will address attendees and webcast viewers.

How can investors watch RxSight's (RXST) presentation on May 13, 2026?

Investors can watch a live webcast and later access an archived recording on the company investor relations website. According to RxSight, the webcast will be available at https://investors.rxsight.com/ for live and on‑demand viewing.

What format will RxSight (RXST) use for its Bank of America Healthcare Conference appearance?

RxSight management will participate in a fireside chat format at the conference. According to RxSight, the session is scheduled as a moderated discussion rather than a formal earnings presentation.

Will the RxSight (RXST) webcast from the conference be archived?

Yes, the presentation will be archived for later viewing on the investor relations site. According to RxSight, both a live webcast and an archived version will be posted at investors.rxsight.com.

Where is the Bank of America Healthcare Conference presentation by RxSight (RXST) listed for timing and access?

The presentation is listed for May 13, 2026 at 3:00 p.m. PT and accessible via the investor relations site. According to RxSight, timing and the webcast link are available at https://investors.rxsight.com/.